VRTX · Earnings call · 2026Q3T · Full report
Capital Return Program
VERTEX PHARMACEUTICALS INC / MA · 2026-11-02 · Importance 27 · Surprise 6 · In source text
Vertex repurchased approximately $120 million of shares during the third quarter, buying roughly 250,000 shares. Year to date, it repurchased approximately 2 million shares for $921 million. Management said capital deployment remains focused first on innovation, including external innovation, with an additional allocation for share repurchases.
Key facts
- Year to date in 2026, Vertex repurchased approximately 2 million shares for $921 million.
- Vertex repurchased roughly 250,000 shares for approximately $120 million during Q3 2026.
- Vertex's capital deployment priority remains investment in innovation, including external innovation, with an additional allocation for share repurchases.
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | realized | -2.8% | Year to date in 2026, Vertex repurchased approximately 2 million shares for $921 million. |